Thursday, 29 August 2019

Syphilis : The Monalisha: A spirochete always difficult to trace her : Diag dilemma of Syphilis, Preg : neonatal transmission rate


Q.1: What are the 3 basic tests that can be ordered if couple can afford to remove apprehension about Treponemal infections?? Ans:--There are three basic methods used in screening for syphilis. These include A) direct observation of the spirochete by dark field microscopy, and B) nontreponemal and treponemal serologic antibody studies.
 Pont 2:  Q. What are the limitations & utility of VDRL test ? Ans: As most of us still remember that the abbreviation VDRL implies:” Ans:   The venereal disease research laboratory (VDRLtest”. This tests is used to detect if a person has been infected with the bacteria causing syphilis, which is a sexually transmitted disease. The test detects the presence of antibodies against the bacteria Treponema pallidum.  )
Point 3:- Q.3: What is the main limitations of VDRL tests?? Ans-VDRL test is used for initial screening, & more sensitive nontreponemal tests such as the rapid plasma reagin (RPR) . Whereas specific treponemal tests such as the fluorescent treponemal antibody absorption (FTA-ABS) are used to confirm the diagnosis. The importance of these screening tools is shown by past clinical studies that have demonstrated 78% accuracy for the clinical diagnosis of primary syphilis by experienced clinicians.
Point 4: There are basically two confirmagtory teats  a) Having admitted that observing spirochete in dark ground illumination is direct test and  also  b) The second confirmatory is  FTA-ABS test which should be performed if VDRL or RPR is positive . But what are the indirect (inconclusive ) tests ?? How useful are serological tets for treponemal?? Can second kind of tes be fasle positive ?? What is called Biological Flase Positive Recations?? Ans:_Serologic tests provide only indirect evidence of syphilis and may be reactive in the absence of clinical, historical, or epidemiologic evidence of syphilis. The reactivity in such cases is usually in low dilutions (<1:8), however, in exceptional cases false reactivity in very high titers (up to 1:256) has been reported; therefore, quantitative titer cannot be used to differentiate between a false-positive reaction and syphilis. This is especially true for persons who are IV drug users, where more than 10% have false positivity with titers >8. False-positive reactions can also occur with treponemal tests, but this is less common than with nontreponemal tests Therefore, careful clinical interpretation of test results and other evidence is necessary for proper diagnosis. Besides being BFP reaction, another factor needed to be look into is reliability of technique and the quality of the laboratory where it is done, because incidence of positivity increases due to faulty procedure or wrong interpretation. BFP reaction is for inherent reasons and not due to any technical error. BFP reactions comprise a high proportion of all VDRL reactors. Therefore, the use of the VDRL as a screening procedure is challenged. Therefore, before giving any conclusive opinion in regards to VDRL reactivity, we need to take a proper history regarding any chronic illness such as, systemic lupus erythematosus, rheumatoid arthritis or any autoimmune or collagen disease, antiphospholipid syndrome, d

 Point 4 :-Q. What are the limitations of Rapid plasma reagin (RPR) and the VDRL tests?? Ans:- are used for initial screening These two are nonspecific test but it is useful in follow up Tr  , since the antibody titer declines on successful therapy. Dear members pl do remember these are A) Nontreponemal tests and such tests are rapid, simple, and inexpensive. They are the only tests which is principally recommended to monitor the course of disease during and after treatment. B) such nontreponemal tests can also serve to detect reinfection. The main limitations of nontreponemal tests are their reduced sensitivity in primary syphilis and late latent syphilis, false-positive results due to cross reactivity, and the potential for false-negative results due to prozone phenomenon. Unfortunately, no current laboratory test can distinguish one trepanomatosis from another, and this must be considered in serology in areas of the world where yaws, pinta on endemic trepanomatosis exist.
Point 5 : What tests used to be done in good old days ?? -Since very long time Venereal Disease Research Laboratory (VDRL) test was to be performed solely by physicians to screen patients for syphilis, yet VDRL is still the most commonly used test all over the world for screening and it still remains unchallenged Unfortunately in this test, the antibody detects antigens, which are nonspecific, thereby yielding much false-positive reactionThe basis of the VDRL test is that body produces antibody when infected, and in this VDRL test the antibody is detected by subjecting the serum to an antigen, which is composed of colorless alcoholic solution of beef cardiolipin, cholesterol, and lecithin. It is a qualitative test for screening of syphilis, and currently all nontreponemal tests are flocculation tests and both VDRL and RPR tests are modifications of original Wasserman reaction.
Point 6:-Nontreponemal screening tests have a sensitivity of 70–90% in primary syphilis. st should be repeated and a treponemal test should also be performed.
All serological tests are reactive in the early latency; however, the reactivity of the nontreponemal tests decreases with the increasing duration of latency, and in approximately 30% patients with late latent or late syphilis VDRL/RPR teIt needs to be confirmed by a treponemal test. All serological tests are positive at secondary stage and sensitivity for all tests including VDRL test which is approximately 100%; however, in 1–2% of patients’ false-negative nontreponemal tests can occur due to prozone phenomenon. A presumptive diagnosis is based on the presence of typical rash and reactive non-treponemal tests in a titer ≥1:8 in a patient with no previous history of syphilis. If history of syphilis is present, then the criteria should be a fourfold rise in titer. When a titer of nontreponemal test <1:8, the test are negative. In all patients with late latent syphilis, lumbar puncture is recommended to exclude neurosyphilis.In low prevalence populations, false-positive results are common with both treponemal and nontreponemal tests.
Q.7: Dr Pal, How can we confirm congenital syphilis ?? The diagnosis of congenital syphilis is complicated by the trans-placental transfer of maternal nontreponemal and treponemal IgG antibodies to the fetus. This transfer of antibodies makes the interpretation of reactive serologic tests for syphilis in infants difficult. Treatment decisions frequently must be made on the basis of (1) identification of syphilis in the mother; (2) adequacy of maternal treatment; (3) presence of clinical, laboratory, or radiographic evidence of syphilis in the infant; and (4) comparison of maternal (at delivery) and infant nontreponemal serologic titers using the same test and preferably the same laboratory. Venous blood from both the mother and the child should be tested. Asymptomatic congenital syphilis requires a comprehensive approach. All infants born to mothers who have reactive nontreponemal and treponemal test results should be evaluated with a quantitative nontreponemal serologic test (RPR or VDRL) performed on infant serum because umbilical cord blood can become contaminated with maternal blood and could yield a false-positive result and should be examined thoroughly for evidence of congenital syphilis (e.g., nonimmune hydrops, jaundice, hepatosplenomegaly, rhinitis, skin rash, and/or pseudo paralysis of an extremity). Conducting a treponemal test (i.e., TP-PA or FTA-ABS) on a newborn's serum is not necessary.


Point 8:-What is called as “biological false-positive (BFP) VDRL test” ?? Ans;-This is only an indirect evidence of syphilis - The prevalence of BFP is generally 1–2%. Serologic tests provide only indirect evidence of syphilis and may be reactive in the absence of clinical, historical, or epidemiologic evidence of syphilis. The VDRL usually becomes reactive within the first few weeks after infection, peaks during the first year, and then slowly declines, so that low titers (levels) are seen in late syphilis.
Q. 9:-Dr Pal , can U briefly  mention the relevance of VDRL(screening tets ) in cases of HIV infected mother ?? Relation of HIV and VDRL Test
The interaction between syphilis and HIV infection is complex and remains incompletely understood, despite there being more than two decades of clinical experience with co-infected patients.
Serologic tests for syphilis are the cornerstone of diagnosing untreated syphilis infection, independent of HIV status. Nontreponemal assays, such as the RPR card or VDRL test, use cardiolipin-, lecithin-, and cholesterol-containing antigen to measure antilipoidal antibodies and are often used initially to diagnose syphilis. The sensitivity of nontreponemal and treponemal tests for syphilis increases with duration of infection, and ranges from approximately 75% in the primary stage to virtually 100% in the secondary stage. Because the sensitivity of nontreponemal tests is lower that that of treponemal tests in the primary stage, a negative nontreponemal test in an HIV-infected individual with a genital lesion cannot exclude primary syphilis. It may be useful to consider both a nontreponemal and a (nonreflexed) treponemal test as a diagnostic strategy in newly infected persons with suspicious lesions. Unusual serologic responses have been reported in HIV-infected persons with syphilis. Most reports involved higher than expected serologic titers, but false-negative serologic results and delayed appearance of sero-reactivity have also been reported, albeit rarely. Nevertheless, serologic tests appear to be accurate and reliable for the diagnosis of syphilis and the evaluation of treatment response in most HIV-infected patients. The clinician should seek confirmatory evidence for the diagnosis from any available source, including the patient's history, clinical findings, direct examination of lesion material for spirochetes, and serologic tests for syphilis. Reports of nontreponemal antibody test results should be quantitative and describe the lowest dilution (i.e., the titer) at which the test result is reactive. In general, nontreponemal test titers may be higher among HIV-positive patients than among HIV-negative persons.

Q. 11. What will be threatment& follow up?? VDRL and Treatment Follow-up
There is no ideal test of cure of syphilis available that can be carried out within days or weeks after treatment to determine the status of a patient. Patients should have serological tests for syphilis done on the day treatment is initiated. To access it, the patient is asked to repeat quantitative nontreponemal serological testing like VDRL/RPR and clinical evaluation at 3, 6, and 12 months. When serological test is negative, patient is assured to be cured. Generally, seropositivity is achieved in majority of the patients with primary syphilis in about 12 months after the treatment and in those with secondary syphilis in about 24 months. Seroconversion is more rapid after therapy if duration of infection is short and initial titer is low. As seroconversion is a slow process requiring months to years, the rate of decline is a better indicator of therapeutic response. A 4-fold decrease in titer is considered as good response, and this should occur within 3-6 months after therapy in patients with primary and secondary syphilis and within 12 months in patients with early latent syphilis. The VDRL titer may not decrease in patients with late syphilis and remains reactive at a low level (<1:8) for many years after adequate treatment. There is no satisfactory monitoring test available for nontreponemal test-negative late disease.  Nontreponemal tests are then monitored at a 6-month interval in patients with latent disease without neurosyphilis to document a fourfold decrease/seronegativity within 24 months after treatment. Low titers will persist in approximately 50% of patients with late syphilis after adequate therapy after 2 years. This low titer persistent seropositivity does not signify treatment failure or reinfection, and these patients are likely to remain serofast even if they are retreated. The FTA-abs (DS) is not recommended for treatment follow-up. Nonreactive serologic tests and normal clinical evaluation cannot exclude incubating syphilis.
In patients with neurosyphilis VDRL-CSF is repeated at 4- to 6-month interval, if CSF pleocytosis or CSF-VDRL titers are noted initially. Some experts recommend that HIV-infected patients be followed more closely at 3-month interval.
The literature VDRL reactor values for treated late latent syphilis and treated late manifest syphilis are 1% only..Although higher values may have been reported, they were unaccompanied by a specification as to the interval lapsed between the times of treatment and testing.. Moreover, not even untreated latent syphilis or late syphilis exceeds the VDRL reactivity of 70% (30% of the diseased spontaneously become negative).
The criteria for treatment failure currently include the following findings:
Persistence, recurrence, or development of clinical signs or symptoms of syphilis in the absence of reinfection.
Sustained (greater than 2 weeks) fourfold (two dilutions) increase in the nontreponemal test titer (assuming the same test type was used [e.g., VDRL, RPR].
Failure of the initial nontreponemal test titer to decrease fourfold (two dilutions) by 6–12 months for primary, secondary, or early latent syphilis and by 12–24 months for late latent syphilis or syphilis of unknown duration
Point 12: Take home message: Practice Guidelines :--The diagnosis of infection is commonly performed using the VDRL and TPHA tests. This is a nonspecific test but it is useful in following treatment, since the antibody titer declines on successful therapy. It also impresses on nonvenereologists the need to cautiously order and interpret serological tests for the demonstration of syphilis. This subsumes quantifying the VDRL among the infected, and the use of modern tests to determine the intensity of syphilitic process. In general, the sensitivity of treponemal tests continues to approximate 100% in late syphilis, in contrast to nontreponemal tests, which are more practical and cost-effective for initial screening but have diminished sensitivity in late syphilis. Despite the higher sensitivity of treponemal tests, they have not been recommended for initial screening in the many countries, primarily because of cost.
It is always advisable to interpret properly before giving any diagnosis to avoid any legal complications in future, so also for the psychological well-being of the patient. In accord with all diagnostic methods, a





No comments:

Post a Comment